At any time, managing a supply chain to ensure that clinical laboratories have ready access to the tests, reagents, and consumables they need to meet diagnostic demand can be a challenge — and that’s a challenge shared by healthcare systems, manufacturing companies, distributors, and even individual labs. But in a pandemic, that challenge becomes a […]
In Canada, AI helps allocate COVID-19 tests accurately and fairly Read More »
Thanks to its availability and affordability, next-generation sequencing (NGS) has been an integral component of the scientific community’s response to the COVID-19 pandemic. Genomic data has enabled unprecedented pathogen surveillance and rapid development of diagnostic tests and vaccines based on the viral genome sequence. The very first look at the SARS-CoV-2 genome came from scientists
How NGS tools have shaped the COVID-19 pandemic response Read More »
Optimism about the development and rollout of vaccines for COVID-19 has spurred efforts to efficiently record and authenticate those who have been vaccinated. This has inspired new discussions of how to create a ‘vaccination passport’ that would allow the carrier to be able to travel between countries, return to work, go to school, attend events
For vaccination ‘passports’, the past offers a glimpse at the challenges ahead Read More »
The ongoing COVID-19 pandemic has had a profound worldwide impact on the Thrombosis and Hemostasis community. Nevertheless, the pace of COVID-19 coagulation-related research has continued to accelerate and has established the role of laboratory coagulation data for many purposes, including disease prognosis and outcome. Although the pathogenesis of the COVID-19-induced coagulopathy has not yet been
Coagulation during COVID-19 and beyond: diagnostic challenges and opportunities Read More »
In a recent webinar hosted by Roche Diagnostics Asia Pacific, Professor Aw Tar Choon, Senior Consultant at the Department of Laboratory Medicine at Singapore’s Changi General Hospital, shares key updates on COVID-19 testing, including the growing array of rapid tests that provide quick return on results. Prof Aw explores the viral kinetics of SARS-CoV-2, which
COVID-19 testing: Prof Aw Tar Choon on PCR, antigen and serology strategies Read More »
Listen to Caroline Riady, Vice President Director of Siloam Hospitals in Indonesia, share the journey of how Siloam Hospitals stepped up to the challenge of COVID-19 to serve the people of Indonesia. As part of that journey, Siloam Hospitals launched various digital solutions for better patient education and engagement, placing the patient and community at
Siloam Hospitals pursues digital transformation to take on COVID-19 pandemic Read More »
With only 500 confirmed cases and 7 deaths from COVID-19 as of mid-September, Taiwan is widely regarded as a success story in COVID-19 containment. Rapid mobilisation of clinical lab resources played an important role in the containment efforts, according to Dr Fang-Yeh Chu, Director in the Department of Clinical Pathology and QMC at Far Eastern
COVID-19 in Taiwan: how clinical labs are driving successful containment Read More »
In a recent webinar hosted by Roche Diagnostics Asia Pacific, Dr James Ho, a Clinical Associate Professor in the Department of Medicine at the University of Hong Kong, shared insights on the current state of lung cancer diagnostics and how COVID-19 is impacting patient care. The webinar begins with an overview of the key diagnostic tools
Lung cancer diagnostics in the COVID-19 era: insights from Dr James Ho Read More »
In the ongoing fight against the COVID-19 pandemic, many healthcare systems are adding interleukin-6 (IL-6) to their diagnostic toolkit. An early predictor of severe COVID-19, IL-6 is an ideal prognostic biomarker because it can be detected from an easily accessible biological source (serum or plasma) and via well-characterised, rapid assay systems. A growing body of
IL-6 shows promise for COVID-19 management in Asia Pacific Read More »
As Director of the Point-of-Care Testing Center for Teaching and Research (POCT•CTR) and Professor Emeritus of Pathology and Laboratory Medicine at the University of California Davis School of Medicine, Dr Gerald Kost is one of the world’s leading experts in point-of-care testing (POCT). He is also a Fulbright Scholar 2020-21 in ASEAN. In this Q&A,
Point-of-care testing for pandemic management: an interview with Dr Gerald Kost Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
